These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4390125)

  • 1. Interaction between histamine and monoamine oxidase inhibitors.
    Allen GS; Rand MJ
    J Pharm Pharmacol; 1969 May; 21(5):317-22. PubMed ID: 4390125
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.
    Trinker FR; Fearn H; McCulloch MW; Rand MJ
    Aust Dent J; 1967 Aug; 12(4):297-303. PubMed ID: 5233628
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute cardiovascular effects of several monoamine oxidase inhibitors in dogs].
    Bouyard P; Klein M; Loubatières A
    C R Seances Soc Biol Fil; 1966; 160(1):171-4. PubMed ID: 4222909
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of adrenergic drugs on morphine-induced hyperglycemia.
    Clissiounis N
    Life Sci; 1979 Jul; 25(4):391-4. PubMed ID: 470556
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversal of the bronchodilator action of ephedrine during ventilation with carbon dioxide.
    Pun LQ; Atkinson JM; Rand MJ
    Eur J Pharmacol; 1971 Jun; 15(1):110-8. PubMed ID: 5161326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between phenylpropanolamine and monoamine oxidase inhibitors.
    D'Mello A
    J Pharm Pharmacol; 1969 Sep; 21(9):577-80. PubMed ID: 4390334
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of pharmacological activity and toxicity of the antidepressants nialamide, phenelzine and iproniazide].
    Lapin IP; Samsonova ML
    Farmakol Toksikol; 1969; 32(5):526-30. PubMed ID: 5364661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic effect on the adrenergic mechanisms of heart blood supply regulation].
    Zakusov VV; Kaverina NV
    Kardiologiia; 1967 Nov; 7(11):45-54. PubMed ID: 4979866
    [No Abstract]   [Full Text] [Related]  

  • 17. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice.
    Carlsson A; Waldeck B
    J Pharm Pharmacol; 1967 Mar; 19(3):182-90. PubMed ID: 4382340
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor.
    Cuthbert MF; Vere DW
    Br J Pharmacol; 1971 Oct; 43(2):471P-472P. PubMed ID: 5158241
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of monoamine oxidase inhibitors on spinal synaptic activity.
    Anderson EG; Baker RG; Banna NR
    J Pharmacol Exp Ther; 1967 Dec; 158(3):405-15. PubMed ID: 5299660
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.